TipRanks
Go Ultimate55% OFF

Riken Vitamin Co., Ltd. (4526) Stock Price & Analysis

4526 Stock Chart & Stats

¥3,435.00¥65.00(1.93%)
At close: 3:30 PM GMT+9
JPY 3,100JPY 3,200JPY 3,300JPY 3,4003 Aug17 Aug31 Aug14 Sep28 Sep13 Oct26 Oct
Day’s Range
JPY 3,360.00 - JPY 3,445.00
52-Week Range
JPY 2,662.00 - JPY 3,470.00
Previous Close
JPY 3,370.00
Volume
59.00K
Average Volume (3M)
103.12K
Market Cap
JPY 78.33B
Enterprise Value
JPY 78.70B
Total Cash (Recent Filing)
JPY 17.91B
Total Debt (Recent Filing)
JPY 7.40B
Price to Earnings (P/E)
14.2
Beta
0.35
Next Earnings
Nov 12, 2026 (Est.)
EPS Estimate
N/A
Dividend Yield
3.20%

Bulls Say, Bears Say

Bulls Say

Conservative Balance Sheet

Very low leverage and a growing equity base reduce financial risk and preserve flexibility for investment, procurement needs and potential downturns. This strengthens the company’s ability to sustain operations while funding its food and materials businesses.

Steady Revenue And Solid Profitability

Continued revenue expansion and positive category-level margins indicate an established operating base and recurring demand. Although profitability has moderated, the company remains materially improved from its 2021 loss and continues to generate earnings.

Diversified Food And Functional Materials Model

Exposure to both food-supply-chain demand and industrial applications diversifies end markets and revenue drivers. Value-added ingredients, formulations and functional materials can support customer retention and reduce reliance on a single product category.

Bears Say

Sharp Free Cash Flow Decline

The steep reduction in free cash flow weakens cash conversion and may reflect higher reinvestment or working-capital requirements. If sustained, it could constrain internally funded growth and reduce the durability of shareholder distributions.

Margin Normalization

Profitability has cooled from its recent peak, indicating that prior margin gains may not be fully durable. Continued normalization could limit earnings growth unless manufacturing efficiency, product mix or pricing offsets procurement and operating-cost pressure.

Earnings Growth Pressure

Negative EPS growth despite modest revenue expansion shows that earnings are currently lagging the top line. Persistent pressure on per-share profitability could reduce the company’s ability to compound returns unless margins and cash conversion recover.

Riken Vitamin Co., Ltd. News

4526 FAQ

What was Riken Vitamin Co., Ltd.’s price range in the past 12 months?
Riken Vitamin Co., Ltd. lowest stock price was ¥2662.00 and its highest was ¥3470.00 in the past 12 months.
What is Riken Vitamin Co., Ltd.’s market cap?
Riken Vitamin Co., Ltd.’s market cap is ¥78.33B.
When is Riken Vitamin Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Riken Vitamin Co., Ltd.’s earnings last quarter?
Riken Vitamin Co., Ltd. released its earnings results on Aug 07, 2026. The company reported ¥64.16 earnings per share for the quarter.
Is Riken Vitamin Co., Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Riken Vitamin Co., Ltd. pay dividends?
Riken Vitamin Co., Ltd. pays a Semiannually dividend of ¥55 which represents an annual dividend yield of 3.2%. See more information on Riken Vitamin Co., Ltd. dividends here
What is Riken Vitamin Co., Ltd.’s EPS estimate?
Riken Vitamin Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Riken Vitamin Co., Ltd. have?
Riken Vitamin Co., Ltd. has 30,705,100 shares outstanding.
What happened to Riken Vitamin Co., Ltd.’s price movement after its last earnings report?
Riken Vitamin Co., Ltd. reported an EPS of ¥64.16 in its last earnings report. Following the earnings report the stock price went up 0.799%.
Which hedge fund is a major shareholder of Riken Vitamin Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4526
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology